期刊文献+

长效注射给药系统的体外释药评价 被引量:3

Evaluation of in vitro release from long-acting injectable system
原文传递
导出
摘要 近几年,长效注射给药系统作为一种新型的缓控释非胃肠道给药系统,因具有传统给药系统所不能比拟的优势,其在临床、科研领域都引起了颇多关注。在长效注射剂研发过程中,建立适当的体外释药方法是保证其质量、特性以及各批次间稳定性的关键步骤。本文对用于该系统的3种常见体外释药实验原理,3类典型释药新技术的体外常速释药及相关加速释药研究进行综述。 In recent years, long-acting injectable system as a novel controlled release parenteral drug deliv- ery system has attracted considerable attention in clinical and research fields because of its advantages compared with traditional drug delivery systems. In the process of long-acting injection development, the establishment of ap- propriate in vitro release methods is the key steps to guarantee the quality, features and stability of each batch. In this paper, three in vitro release experimental principles commonly used in the system, constant speed in vitro re- lease of three typical new release technologies and the related acceleration speed release studies were reviewed.
出处 《中国新药杂志》 CAS CSCD 北大核心 2014年第5期541-549,共9页 Chinese Journal of New Drugs
基金 国家基础研究973项目(2012CB724002) 国家重大新药创制项目(2014ZX09507-005-01)
关键词 长效注射剂 体外释药模型 常速释药 加速释药 数学模型 long-acting injections in vitro release models constant speed release acceleration speed re-lease mathematical model
  • 相关文献

参考文献62

  • 1LARSEN C , LARSEN SW, JENSEN H, et al. Role of in vitrorelease models in formulation development and quality control ofparenteral depots [ J]. Expert Opin Drug Deliv,2009 , 6( 12):1283 - 1295.
  • 2SHEN J, BURGESS DJ. Accelerated in-vitro release testingmethods for extended-release parenteral dosage forms [ J] . JPharm Pharmacol, 2012 ,64 (7 ) : 986 - 996.
  • 3THING M,LARSEN C, 0STERGAARD J, et al. In vitro releasefrom oil injectables for intra-articular administration : Importanceof interfacial area, diffusivity and partitioning [ J]. Eur J Pharm,Sci, 2012,45(3) :351 -357.
  • 4D'SOUZA SS,DELUCA PP. Methods to assess in vitro drug re-lease from injectable polymeric particulate systems [ J] . PharmRes,2006,23 (3) :460 -474.
  • 5SCHULTZ K,M0LLGAARD B,FROKJAER S, et al. Rotatingdialysis cell as in vitro release method for oily parenteral depot so-lutions[J]. Int J Pharm, 1997,157(2) : 163 - 169.
  • 6D,SOUZA SS, DELUCA PP. Development of a dialysis in vitrorelease method for biodegradable microspheres[ J] . AAPS PharmSci Tech, 2005,6(2) :E323 -E328.
  • 7YANG F, SHU YJ, YANG YQ , et al. The pharmacokinetics ofrecombinant human interferon-alpha-2b poly ( lactic-co-glycolicacid) microspheres in rats [ J]. J Microencapsul,2011 ,28(6):483 -489.
  • 8CHANG LC , YANG CY, CHUA ACN , et al. Sustained releaseof transgenic human factor IX : preparation,characterization,andin vivo efficacy [ J]. Mol Pharm, 2011,8(5): 1767 - 1774.
  • 9LI ZP, LI L, LIU Y , et al. Development of interferon alpha-2bmicrospheres with constant release [ J] . Int J Pharm, 2011 ,410.1):48 -53.
  • 10HE JT, FENG MY, ZHOU XL, et al. Stabilization and encapsu-lation of recombinant human erythropoietin into PLGA micro-spheres using human serum albumin as a stabilizer[ J]. Inter JPWm,2011 ,416(1) :69 -76.

二级参考文献66

共引文献28

同被引文献17

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部